- Home
- PXS vs TPST Comparison
PXS vs TPST Comparison
Compare PXS & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PXS
- TPST
- Stock Information
- Founded
- PXS 2015
- TPST 2011
- Country
- PXS Greece
- TPST United States
- Employees
- PXS N/A
- TPST N/A
- Industry
- PXS Marine Transportation
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- PXS Consumer Discretionary
- TPST Health Care
- Exchange
- PXS Nasdaq
- TPST Nasdaq
- Market Cap
- PXS 29.7M
- TPST 33.0M
- IPO Year
- PXS N/A
- TPST N/A
- Fundamental
- Price
- PXS $2.98
- TPST $6.66
- Analyst Decision
- PXS Strong Buy
- TPST Hold
- Analyst Count
- PXS 1
- TPST 3
- Target Price
- PXS $10.00
- TPST $30.00
- AVG Volume (30 Days)
- PXS 26.3K
- TPST 72.4K
- Earning Date
- PXS 08-11-2025
- TPST 08-07-2025
- Dividend Yield
- PXS N/A
- TPST N/A
- EPS Growth
- PXS N/A
- TPST N/A
- EPS
- PXS 0.63
- TPST N/A
- Revenue
- PXS $49,342,000.00
- TPST N/A
- Revenue This Year
- PXS N/A
- TPST N/A
- Revenue Next Year
- PXS $31.36
- TPST N/A
- P/E Ratio
- PXS $4.65
- TPST N/A
- Revenue Growth
- PXS 8.07
- TPST N/A
- 52 Week Low
- PXS $2.53
- TPST $5.35
- 52 Week High
- PXS $5.53
- TPST $29.38
- Technical
- Relative Strength Index (RSI)
- PXS 54.92
- TPST 42.36
- Support Level
- PXS $2.76
- TPST $6.57
- Resistance Level
- PXS $3.05
- TPST $7.05
- Average True Range (ATR)
- PXS 0.08
- TPST 0.26
- MACD
- PXS 0.01
- TPST -0.06
- Stochastic Oscillator
- PXS 77.11
- TPST 8.45
About PXS Pyxis Tankers Inc.
Pyxis Tankers Inc is an international maritime transportation company focused on mid-sized eco-vessels for the product tanker and dry-bulk sectors. It owns a fleet that comprises double-hull product tankers employed under a mix of short- and medium-term time charters and spot charters. The fleet owned by the company includes Konkar Ormi, Pyxis Lamda, Konkar Venture, Pyxis Karteria, and others. Each of the vessels in the fleet is capable of transporting refined petroleum products, such as naphtha, gasoline, jet fuel, kerosene, diesel, fuel oil, and other liquid bulk items, such as vegetable oils and organic chemicals. The company operates under two reportable segments, Tanker Vessels, which derive maximum revenue, and Dry-bulk Vessels.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.